Form 4: BioSig Technologies Director Acquires 500,000 Shares of Common Stock

Frederick Hrkac, a director of BioSig Technologies, acquired 500,000 shares of common stock on March 1, 2024, as part of a restricted stock grant for services.

Summary

• On March 1, 2024, Frederick Hrkac, a director of BioSig Technologies, acquired 500,000 shares of common stock.
• The acquisition was a grant of restricted stock for services.
• The shares were granted at a price of $0 per share, based on a closing price of $0.705 per share.
• The shares vested immediately on the date of the grant, March 1, 2024.
• Following the transaction, Mr. Hrkac beneficially owns 509,501 shares of common stock, reflecting the reverse stock split that went into effect on February 2, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director. While insider buying can be seen as positive, this was a grant for services, so it doesn't necessarily indicate strong bullish sentiment.

Positives

• A director's acquisition of shares can be seen as a positive signal, indicating confidence in the company's future.

Industry Context

This filing is a routine disclosure related to insider transactions and doesn't necessarily reflect broader industry trends.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director increasing their stake in the company.

Key Dates